CommercialCoverageMedium impact
11.17.06t, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)
Independence Blue Cross·Urology·Medical Policy
Effective date
Mar 24, 2025
We identified it
Jun 19, 2026
Summary
IBX has updated their medical policy for surgical and minimally invasive treatments for urinary outlet obstruction due to benign prostatic hyperplasia (BPH). The changes affect medical necessity criteria, medical coding, and general policy guidelines for BPH-related procedures.
Action Required
By March 24, 2025: Billing team must review updated IBX medical policy 11.17.06t for BPH surgical procedures to understand new medical necessity criteria and coding guidelines. Update internal billing protocols and staff training materials to reflect new requirements. Verify that documentation requirements are met before submitting BPH-related surgical claims to avoid denials.